Abstract
Serial carcinoembryonic antigen (CEA) assays were conducted in patients with endocrine-unresponsive prostatic adenocarcinoma who were being treated with multidrug chemotherapy. Changes in CEA correlated with the clinical status of the patient in 70 per cent of the determinations and were more accurate than acid phosphatase in monitoring the response to treatment.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Acid Phosphatase / blood
-
Adenocarcinoma / drug therapy
-
Adenocarcinoma / immunology*
-
Carcinoembryonic Antigen / analysis*
-
Drug Therapy, Combination
-
Fluorouracil / therapeutic use
-
Humans
-
Male
-
Melphalan / therapeutic use
-
Methotrexate / therapeutic use
-
Neoplasm Metastasis
-
Prednisone / therapeutic use
-
Prostatic Neoplasms / drug therapy
-
Prostatic Neoplasms / immunology*
-
Vincristine / therapeutic use
Substances
-
Carcinoembryonic Antigen
-
Vincristine
-
Acid Phosphatase
-
Melphalan
-
Fluorouracil
-
Prednisone
-
Methotrexate